BOSTON - Sept. 11, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies.
Novotech is collaborating with Endpoints News to jointly host this webinar.
The webinar will examine how China’s focus on cutting-edge innovations and collaborations is attracting international biotech companies seeking to unlock the potential of advanced therapies including immuno-oncology, vaccines, cell & gene, and RNA.
China accounted for 27.7% of the global clinical trials activity in 2022, according to GlobalData.
The panel will also discuss the significant benefits China offers clinical stage biotech companies including but not limited to: strong appetite from foreign sponsors to run trials, lower trial density and low risk of competing trials, large pools of patients, high patient recruitment rates, high number of active investigators and efficient regulatory pathways.
